Local Haemodynamic Effects of Apelin Agonists and Antagonists in Man in Vivo

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Cardiovascular Disease
Interventions
PROCEDURE

Forearm venous occlusion plethysmography

Forearm venous occlusion plethysmography to study to measure forearm blood flow during intra-arterial infusion of the apelin peptides.

PROCEDURE

Aellig hand vein technique

Hand vein measurements will be used to assess the response to apelin peptides and apelin receptor blocker in the human hand vein vascular bed.

OTHER

Apelin agonist infusion

Escalating doses of apelin (1/10/100nmol/min) will be administered.

OTHER

Apelin receptor antagonist infusion

Dose finding study (range 1-300nmol/min) and co-infusion study with apelin peptides

Trial Locations (1)

CB2 0QQ

Vascular Research Unit, Cambridge

All Listed Sponsors
lead

University of Cambridge

OTHER

NCT02150694 - Local Haemodynamic Effects of Apelin Agonists and Antagonists in Man in Vivo | Biotech Hunter | Biotech Hunter